Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea

Figure 3 Diagnostic accuracy of non-alcoholic fatty liver disease fibrosis score to predict carotid atherosclerosis in patients with obstructive sleep apnea. A: Receiver operating characteristic curve for non-alcoholic fatty liver disease fibrosis score and fibrosis-4 to predict carotid atherosclerosis in patients with obstructive sleep apnea (n = 112); B: Receiver operating characteristic curve for the non-alcoholic fatty liver disease fibrosis score model along with arterial hypertension and current smoking status to predict carotid atherosclerosis in patients with obstructive sleep apnea (n = 112). NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4; AUROC: Area under the receiver operating characteristic curve.